Find trials
Search tips

Prognostic and Predictive Biomarkers in Neuroendocrine Tumors

Overview

About this study

The purpose of this study is to identify prognostic biomarkers of neuroendocrine carcinomas. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with neuroendocrine tumors seen in Medical Oncology clinic at Mayo Rochester

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Michaela Banck, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20314161

Mayo Clinic Footer